Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane.

Reshetnyak YK, Andreev OA, Segala M, Markin VS, Engelman DM.

Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15340-5. doi: 10.1073/pnas.0804746105. Epub 2008 Sep 30.

2.

Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate.

Gallagher FA, Kettunen MI, Day SE, Hu DE, Ardenkjaer-Larsen JH, Zandt Ri, Jensen PR, Karlsson M, Golman K, Lerche MH, Brindle KM.

Nature. 2008 Jun 12;453(7197):940-3. doi: 10.1038/nature07017. Epub 2008 May 28.

PMID:
18509335
3.

Workshop on the production, application and clinical translation of ''non-standard'' PET nuclides: a meeting report.

Lewis JS, Welch MJ, Tang L.

Q J Nucl Med Mol Imaging. 2008 Jun;52(2):101-6. Epub 2007 Nov 28.

4.

Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia.

Vāvere AL, Lewis JS.

Dalton Trans. 2007 Nov 21;(43):4893-902. Epub 2007 Sep 25.

PMID:
17992274
5.

A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers.

Reshetnyak YK, Segala M, Andreev OA, Engelman DM.

Biophys J. 2007 Oct 1;93(7):2363-72. Epub 2007 Jun 8.

6.

Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo.

Andreev OA, Dupuy AD, Segala M, Sandugu S, Serra DA, Chichester CO, Engelman DM, Reshetnyak YK.

Proc Natl Acad Sci U S A. 2007 May 8;104(19):7893-8. Epub 2007 May 1.

7.

Copper chelation chemistry and its role in copper radiopharmaceuticals.

Wadas TJ, Wong EH, Weisman GR, Anderson CJ.

Curr Pharm Des. 2007;13(1):3-16. Review.

PMID:
17266585
8.

Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelator.

Wei L, Butcher C, Miao Y, Gallazzi F, Quinn TP, Welch MJ, Lewis JS.

J Nucl Med. 2007 Jan;48(1):64-72.

9.

Extracellular pH and P-31 magnetic resonance spectroscopic variables are related to outcome in canine soft tissue sarcomas treated with thermoradiotherapy.

Lora-Michiels M, Yu D, Sanders L, Poulson JM, Azuma C, Case B, Vujaskovic Z, Thrall DE, Charles HC, Dewhirst MW.

Clin Cancer Res. 2006 Oct 1;12(19):5733-40.

10.

Linking oncogenic pathways with therapeutic opportunities.

Bild AH, Potti A, Nevins JR.

Nat Rev Cancer. 2006 Sep;6(9):735-41. Epub 2006 Aug 17. Review.

PMID:
16915294
11.

Hyperthermic biology and cancer therapies: a hypothesis for the "Lance Armstrong effect".

Coffey DS, Getzenberg RH, DeWeese TL.

JAMA. 2006 Jul 26;296(4):445-8. Review. No abstract available.

PMID:
16868303
12.

Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice.

Rofstad EK, Mathiesen B, Kindem K, Galappathi K.

Cancer Res. 2006 Jul 1;66(13):6699-707.

13.

Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics.

Gerweck LE, Vijayappa S, Kozin S.

Mol Cancer Ther. 2006 May;5(5):1275-9.

14.

Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix.

Reshetnyak YK, Andreev OA, Lehnert U, Engelman DM.

Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6460-5. Epub 2006 Apr 11.

15.

Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment.

Cairns R, Papandreou I, Denko N.

Mol Cancer Res. 2006 Feb;4(2):61-70. Review.

16.

High resolution pH(e) imaging of rat glioma using pH-dependent relaxivity.

Garcia-Martin ML, Martinez GV, Raghunand N, Sherry AD, Zhang S, Gillies RJ.

Magn Reson Med. 2006 Feb;55(2):309-15.

17.

Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging.

Tai YC, Ruangma A, Rowland D, Siegel S, Newport DF, Chow PL, Laforest R.

J Nucl Med. 2005 Mar;46(3):455-63.

18.

Imaging hypoxia and angiogenesis in tumors.

Rajendran JG, Krohn KA.

Radiol Clin North Am. 2005 Jan;43(1):169-87. Review.

PMID:
15693655
19.

Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator.

Sprague JE, Peng Y, Sun X, Weisman GR, Wong EH, Achilefu S, Anderson CJ.

Clin Cancer Res. 2004 Dec 15;10(24):8674-82.

20.

Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.

Boswell CA, Sun X, Niu W, Weisman GR, Wong EH, Rheingold AL, Anderson CJ.

J Med Chem. 2004 Mar 11;47(6):1465-74.

PMID:
14998334
Items per page

Supplemental Content

Write to the Help Desk